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Abstract
The molecular mechanisms underlying 6-hydroxydopamine and
ethanol-induced neurotoxicity
Gang Chen
Ethanol and 6-hydroxydopamine (6-OHDA), a Parkinson’s disease (PD) mimetic, are
two toxins to the cerebellum. This study investigated the molecular mechanisms
underlying their neurotoxicities. The work in chapter 2 of this thesis focused on 6OHDA-induced neurodegeneration. Previous studies indicate that impaired function of
the endoplasmic reticulum (ER), commonly referred to as ER stress, is an important
factor in the neuropathology of a wide variety of neurological disorders. This study
demonstrated that 6-OHDA evoked ER-stress and led to apoptosis in SH-SY5Y neuronal
cell line and cultured rat cerebellar granule neurons (CGNs). Furthermore, GSK3β played
a crucial role in mediating 6-OHDA’s neurotoxicity. GSK3β inhibitors and neurotrophic
factor, such as BDNF, protected neural cells against 6-OHDA-induced cell death. The
results suggest that GSK3β is an important intermediate in proapoptotic signaling
cascades that are associated with neurodegenerative disease, thus providing a potential
taget site amenable to pharmacological intervention. The work in chapter 3 explored the
intracellular signaling pathway that responds to ethanol-induced damage to the
cerebellum. Numerous studies have found that early developmental exposure to ethanol
caused profound damage to the cerebellum, leading to significant reduction in cerebellum
volume, weight and protein content. PACT (Rax) / PKR / eIF2α is an important signal
transducing pathway which controls the protein synthesis initiation response to different
stimuli. Previous studies have shown that ethanol exposure decreases the protein content
in rat cerebellum and inhibits protein synthesis initiation in rat heart, liver and skeletal
muscle. This study demonstrated that the expressions of PACT (Rax) / PKR / eIF2α are
developmentally regulated in rat developing cerebellum; ethanol exposure promotes the
association of PACT (Rax) with PKR. Ethanol-induced interaction between PACT(Rax)
and PKR leads to phosphorylation of eIF2α and protein synthesis initiation inhibition.
This inhibition can be enhanced by over-expression of PACT (Rax) and reversed by a
mutated PACT (Rax) gene at serine 18 or PKR inhibitors. The results provide a
novel insight into the molecular mechanism of ethanol toxicity.
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Chapter One: Introduction
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Literature Review

1.

6-Hydroxydopamine, Glycogen Synthase Kinase 3β (GSK3β) and Neuronal
Degeneration

1.1. ER stress and neuronal pathogenesis
The endoplastic reticulum (ER) is an important intracellular compartment that
regulates protein synthesis, protein folding and trafficking, cellular responses to stress,
and intracellular calcium (Ca2+) levels (1-3). Alterations in Ca2+ homeostasis and
accumulation of unfolded proteins in the ER cause ER stress (4;5). A variety of toxic
insults, including Ca2+ ionophores, inhibitors of glycosylation, chemical toxicants, and
oxidative stress can all cause ER stress and ultimately lead to cell death (6-14). Although
the ER plays an essential role in important cell functions, until recently the possible
involvement of the ER dysfunction in neuropathology such as ischemia, epileptic seizures
and Alzheimer’s or Parkinson’s disease has been largely neglected. Much data show that
ER function is disturbed in many acute and chronic diseases of the brain, for example: the
ER-associated degradation of misfolded proteins is affected in Parkinson’s disease, the
unfolded protein response is down-regulated in Alzheimer’s disease, and the ER calcium
homeostasis is disturbed in ischemia (15-23).
Neuronal viability is maintained through a complex interaction network of
signaling pathways that can be perturbed in response to a multitude of cellular stresses. A
shift in one or more of these pathways can alter the fate of a neuron resulting in cell death
or continued survival (24;25). Apoptosis is a mechanism of cell death that plays a
fundamental role during the development of many tissues or organs including the central
nervous system. Apoptosis has traditionally been distinguished in developing tissues on
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the basis of specific morphological and biochemical criteria, including perinuclear
chromatin condensation, cell shrinkage and endonuclease-mediated internucleosomal
DNA fragmentation into a ladder pattern. More recently, the term apoptosis has been
used to describe the programmed biochemical pathways of cell death that accompany
development, tissue injury and degeneration (26;27). Several studies indicated that ER
stress was involved in certain types of neuronal apoptosis (28;29); however, the signaltransducting events that connect ER stress to neuronal degeneration are incompletely
understood (30-32).
1.2. ER stress and GRP78
The ER provides a unique oxidizing environment in which reside numerous
protein chaperones that facilitate and promote the productive folding of proteins and
protein complexes. These chaperones provide two important functions in protein folding
(33-36). First, there are proteins such as protein disulfide isomerase (PDI) and cis-trans
prolyl isomerase that catalyze protein-folding reactions and facilitate proteins to attain
their final folded conformation. Second, there are protein chaperones that do not directly
catalyze protein folding, but rather maintain proteins in a folding-competent state.
Glucose-regulated protein (GRP) 78 is an ER chaperone protein whose expression is
induced during oxidative stress, chemical toxity, treatment with Ca2+ ionophores and
inhibitors of glycosylation. This induction, which is part of the unfolded protein response
(UPR), is required to alleviate ER stress, maintain ER function, facilitate protein folding
and thus protect cells from toxic insults (37;38). GRP78 is now considered an ER stressspecific inducible family of proteins.
1.3. ER stress and GADD153
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A hallmark of the ER stress is the induction of ER stress-specific proteins such as
GADD153 (Growth Arrest and DNA Damage inducible), also known as CHOP (C/EBP
homologus protein) or CHOP10. It is a leucine zipper transcription factor that is present
at low levels under normal conditions, but is robustly expressed in response to stress (3942). GADD153 functions as a negative regulator of C/EBP (CCAAT/enhancer-binding
protein) transcription factors (43). It was originally identified based on its induction
following treatment of cells with growth arresting and DNA damage agents, although
induced expression of the gene has also been strongly tied to ER stress (44;45). In
response to ER stress, the transcription factor GADD153 is induced at the transcriptional
level (46). Several groups have reported that induction of GADD153 correlates with the
onset of apoptosis (47-49). It was reported that cell killing in response to toxins that
induce ER stress was delayed in embryonic fibroblasts derived from mice lacking the
GADD153 gene (50). GADD153 is also regulated at the post-transcriptional level by
phosphorylation. When phosphorylated on serine residues 78 and 81 by p38 MAP kinase,
the transcriptional activation by GADD153 increases (51;52). Most evidence support that
GADD153 negatively regulates cell growth and may induce apoptosis (53-55). However,
the relationship between expression of GADD153 and cell death is still not very clear
(56;57).
1.3. ER stress and caspase 12
Caspase stands for cysteine-dependent aspartate specific protease. All caspases
are synthesized as inactive proenzymes and activated by proteolytic cleavage (58).
Caspases have been divided into several distinct groups based on protein structure and
putative functions (27). Caspase 12 in neurons, and other cells, is primarily associated
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with the ER (59-62). Activation of caspase 12 from pro-caspase 12 is specifically induced
by ER stress (63). Apoptosis triggered through pathways that do not involve the ER, such
as serum deprivation or Fas activation, does not result in activation of caspase 12 (64-66).
One of the properties of caspases is transactivation. Once initiator caspases are activated,
they can proteolytically process executioner caspases (caspase 3, 6 and 7) into their active
form (27). Although cytochrome c released from mitochondria has been believed to be
required for caspase 9 activation during apoptosis (67;68), it was shown that caspase 12
can activate pro-caspase 9. The activated caspase 9 then activated caspase 3 through a
cytochrome C-independent pathway (69). Caspase 3 is one of the key executioners of
apoptosis. During the execution phase of apoptosis, caspase 3 is responsible either
partially or totally for the proteolytic cleavage of many key substrates, such as PARP
(70). Caspase 3 is activated in the CNS in response to a variety of injurious stimuli
including ischemia, exctotoxic insult, neurodegenerative disease and ER stress (71-77).
1.4. ER stress and PERK/eIF2α
To survive and adapt under ER stress conditions, cells have a self-protective
mechanism against ER stress which has been termed the ER stress response (78;79).
There are four functionally distinct responses: First, cells upregulate the genes encoding
ER chaperone proteins to increase protein-folding activity and to prevent protein
aggregation. Second, the protein synthesis will be attenuated to reduce the load of new
protein and to prevent further accumulation of unfolded proteins. Third, misfolded
proteins will be degradated in the ER, and Fourth, cells undergo apoptotic death when
functions of the ER are extensively impaired (80-82). To attenuate translation, this
phenomenon occurs at the level of translational initiation via eIF2α phosphorylation (83-
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86). The factor eIF2α mediates the binding of the initiator Met-tRNA to the ribosome.
Phosphorylation of eIF2α at Ser51 blocks this step and protein synthesis is inhibited. This
induces cell apoptosis (85;87-90). PERK is an eIF2α kinase that is localized to the ER
and responsible for phosphorylation of eIF2α during ER stress (91;92). Activation of
PERK is triggered by the dissociation of GRP78 from its ER luminal domain as a
consequence of ER stress. This leads to oligomerization and trans-autophosphorylation of
PERK (93;94).
1.5. PI3K, GSK-3β and apoptosis
Phosphatidylinositol-3 kinase (PI3K) is one of the most important regulatory
proteins that is involved in different signaling pathways and controlling of key functions
of the cell. Experiments with the use of some specific inhibitors of PI3K or cell
transfection with different PI3K gene variants reveal PI3K being a mediator in the control
of at least two very important cell functions, namely, cell division (as a necessary
component of the signaling pathway initiated by growth factors) and apoptosis (the
progress of which is inhibited by PI3K) (95-99). The protein kinase Akt, which was first
identified in the AKT virus, has been identified as a key downstream effector of PI3K in
signaling cell survival (100-102). Neurotrophic factors such as NGF, BDNF and GDNF
activate the PI3-Akt signaling cascade through corresponding receptor tyrosine kinases
such as the high affinity neurotrophins receptors (Trks) (103). After receptor
dimerization, PI3K is recruited to the plasma membrane where its catalytic subunit
generates lipid second messengers, phosphoinositide phosphates (PIP2, PIP3) at the inner
surface of the plasma membrane. Phosphoinositide-dependent protein kinase-1 (PDK-1)
then acts in concert with PIP2 and PIP3 to phosphorylate and activate Akt (104). One of
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the physiological targets of Akt is glycogen synthesis kinase-3 (GSK-3), which is
inhibited by phosphorylation (105). There are two highly homologous forms of GSK-3 in
mammals, GSK-3α and GSK-3β. GSK-3β is particularly abundant in the central nervous
system where it is neuron specific (106). It has been confirmed that GSK-3 signaling has
been implicated in neurodegeneration and neuronal apoptosis (107). GSK-3 is unusual in
that it appears to be largely regulated by inhibition. One means by which GSK-3 can be
inactivated is through phosphorylation of Ser9 in GSK-3β or Ser21 in the case of GSK3α (108). GSK-3β is also capable of being regulated by an activation pathway. Activation
of GSK-3β can be accomplished by phosphorylation at Tyr216 (Tyr 279 for GSK-3α).
Several cellular stresses including serum deprivation stimulate GSK-3β activity in
cortical neurons prior to the induction of apoptosis (109). Inhibition of PI3K induced a
form of cell death associated with the activation of GSK-3β (110). Expression of an
inhibitory GSK-3β binding protein or a dominant interfering form of GSK-3β reduced
neuronal apoptosis; overexpression of GSK-3β in neurons was sufficient to trigger
neuronal cell death (105;111;112). GSK-3β is also a central compartment of the Wnt
signaling pathway important for proper axis formation during embryonic development
(113) and regulates cyclin D1 proteolysis and subcellular localization (114). However,
the detail of this pathway that connects GSK-3β to apoptosis is still not clear.
1.6. The chemicals and their functions:
1.6.1. 6-Hydroxydopamine (6-OHDA): This is a selective catecholaminergic
neurotoxin widely used to investigate the pathogenesis and progression of
Parkinson’s disease (PD). The specificity of 6-OHDA neurotoxicity has been
associated with its uptake and accumulation by a transport mechanism specific
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for catecholaminergic neurons (115). It has been demonstrated that
intrastriatal injection of 6-OHDA is a useful model for studying
neuroprotective and neurotrophic therapies for PD (116). In this case, 6OHDA selectively eliminates the dopaminergic axons and terminals within a
circumscribed area surrounding the injection site, which is followed by a
degeneration of the parent nigral neurons. 6-OHDA has also been proposed as
a putative neurotoxic factor in the pathogenesis of PD (105). This suggestion
is based on the occurrence of 6-OHDA in both human brain (117) and urine of
parkinsonian patients (118). Under physiological conditions 6-OHDA rapidly
and nonenzymatically oxidized by molecular oxygen to form hydrogen
peroxide (H2O2) and the corresponding p-quinone (119). Although the precise
molecular mechanism of cytotoxicity for 6-OHDA remains uncertain, it has
been often linked to the production of reactive oxygen species (ROS)
(120;121).
1.6.2. Thapsigargin is an effective inhibitor of the Ca2+ ion pump proteins of
intracellular membrane located in sarcoplasmic reticulum (SR) and
endoplasmic reticulum (ER) of skeletal, cardiac, muscle and brain
microsomes (122;123). It interacts strongly with the SR of Ca2+-transport
ATPase. The proposed mechanism of inhibition of Ca2+-ATPase activity
including the inhibition of Ca2+ ion binding and enzyme phosphorylation have
been reported (124-126). We use it as an inducer of ER stress.
1.6.3. Tunicamycin: Tunicamycin is a mixture of homologous antibiotics which
contain uracil, N-acetyl glycosamine, an 11-carbon aminodialdose called
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tunicamine and a fatty acid linked to the amino group. It is an inhibitor of
bacterial and eukaryote N-acetylglucosamine transferases; preventing
formation of N-acetylglucosamine lipid intermediates and glycosylation of
newly synthesized glycoproteins. Tunicamycin blocks the formation of
protein

N-glycosidic

linkages

by

inhibiting

the

transfer

of

N-

acetylglycosamine 1-phosphate to dilichol monophosphate (127).
1.6.4. GSK-3β

inhibitor

(TDZD-8):

TDZD-8

(4-Benzyl-2-methyl-1,2,4,-

thiadiazoline-3,5-dione) is a thiadiazolidinone (TDZD) analog that acts as
highly selective, non-ATP competitive inhibitor of GSK-3β by binding to the
active site of GSK-3β. The molecular mechanism for this is still unknown
(128).
1.6.5. Lithium chloride (LiCl): LiCl acts as a direct uncompetitive inhibitor of
GSK-3β. The hypothesis that GSK-3β is the endogenous target of lithium
action is supported by the genetic data as well as in vivo biochemical data and
while the mechanism remains unknown (129).

2.

Ethanol, PACT/Rax-PKR-eIF2α and protein synthesis

2.1

Fetal Alcohol Syndrome and cerebellar dysfunction
Alcohol has been widely recognized as a neuroteratogen (130) and maternal

alcohol consumption during pregnancy can lead to central nervous system dysfunction in
the new born known as the Fetal Alcohol Syndrome (FAS) (131;132), characterized by
microcephaly, cognitive impairment, growth deficiency, a pattern of distinct facial
features and central nervous system (CNS) disorders (133;134). FAS is considered the
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most common nonhereditary cause of mental retardation (135). It was reported that there
were 12,000 new cases of FAS yearly in 1999 in the US (132). The economic costs of
alcohol abuse were estimated to have been $184.6 billion in 1998 among which FASrelated economic costs were at least $4.15 billion (136). Although only 10-40% of infants
of alcohol consumption women meet the criteria of full syndrome, more of them lack the
characteristic facial defects and growth deficiency of FAS but still have alcohol-induced
mental impairments, refer to as alcohol-related neurodevelopmental disorder (ARND)
(135;137-139).
The cerebellum is recognized for its functions in planning and coordinating
movement, motor learning and plasticity, and maintaining balance (140). The cerebellum
constitutes only 10% of the total volume of the brain but contains more than half of all its
neurons (141). The cerebellum disorders induced by ethanol are common both in humans
(142) and animals (143-146). There are two conspicuous neuronal populations in the
cerebellum that differ both in size and the timing of their neurogenesis. The population of
large Purkinje cells is generated exclusively prenatally in the rat, between gestational
days 13 and 16 (147-149). A large population of small granule cells is formed almost
exclusively postnatally during the first three weeks after birth (150). Alcohol exposure
during the early postnatal period in the rat corresponds to exposure of the human fetus
during part of the third trimester called the trimester equivalent (151;152). The
developing cerebellum is one of the most vulnerable regions to ethanol both in human
and in animals. Numerous animal model systems have been used to characterize FAS and
ARND. One of these studies showed that in the growth of the rat brain but not the body
was decreased, with cerebellum growth being inhibited twice as much compared with the
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rest of the brain by exposure to ethanol (153). Other studies also showed that the ethanol
exposure in rat pups lead to significant reduction in cerebellum volume, weight (154) and
protein content (155). However the molecular mechanism(s) involved in ethanol-induced
decrease in cerebellum size and inhibition of protein synthesis has not been elucidated.
2.2. PACT/Rax, PKR, eIF2α and protein synthesis
The double-stranded RNA-activated protein kinase (PKR) is a 551 (515 in mouse)
amino acid serine/threonine protein kinase ubiquitously expressed in mammalian cells
(156;157). PKR consists of two functionally distinct domains: an N-terminal dsRNA
binding regulatory domain and the C-terminal catalytic domain. PKR is initially
identified as transcriptionally induced by interferon and activated in virus-infected cells
by double-stranded RNA (dsRNA) produced during the virus life cycle (158;159). It has
been demonstrated that PKR is a component of signal transduction pathways mediating
cell growth control, and response to stress (160). PKR can be activated by dsRNA,
cytokines (161) and cell stresses such as growth factor or serum deprivation, bacterial
products and physiochemical stress (162;163). A pair of dsRNA binding motifs located in
the N-terminal domain of PKR act as a sensor to bind dsRNA or protein activators
(which themselves contain dsRNA binding domains) (164). The known protein activators
include PACT (PKR-activating protein) (165-167) and its mouse homologue RAX (168).
PACT/Rax is also a ubiquitously expressed mammalian protein, which will be
phosphorylated at serine 18 following stress, heterodimerizes with PKR and activates it
in absence of dsRNA (169). Serine 18 of PACT/Rax is a crucial phosphorylation site for
activation of PKR. The serine 18 mutated PACT/Rax can still associate with PKR, but
has lost its kinase activity (170). Following binding, there is a conformational change in
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PKR, which results in dimerization and autophosphorylation at Thr-446 and Thr451(171-178). Upon activation, PKR will phosphorylate its down stream substrates and
the main cellular target of PKR phosphorylation is the α-subunit of eukaryotic translation
initiation factor-2 (eIF2α) (179-181). Besides being positively regulated by ds-RNA and
PACT/Rax, PKR can be negatively regulated by its cellular inhibitor, P58, a member of
the tetratricopeptide (TPR) family of proteins (182). P58 is activated upon influenza virus
infection (183) and capable of inhibiting PKR activation and eIF-2α phosphorylation by
direct interaction with PKR and blocking PKR’s dimerization (184).
The eIF2 is a three-subunit protein composed of α-, β- and γ-subunits with
different molecular masses and is required in the first step of initiation of protein
synthesis (185). The function of eIF2α is to mediate the binding of the initiator tRNA,
Met-tRNAi, to the 40S-ribosomal subunit as a complex in a GTP-dependent manner
(186). Upon joining to the 60S ribosomal subunit, GTP is hydrolyzed and eIF2 is released
as eIF2·GDP. Prior to joining Met-tRNAi for another round of initiation, the GDP in eIF2
must be exchanged for GTP. This guanine nucleotide exchange (GNE) reaction is
catalyzed by eIF2B (187;188). When PKR phosphorylates eIF2α at serine-51, it converts
eIF2 from a substrate to an inhibitor of its guanine nucleotide exchange factor, eIF2B
(189). This reduction in recycling of eIF2 by eIF2B leads to inhibition of translation
initiation (190). Phosphorylation of the -subunit in eIF2 occurs in cells or in cell-free
translational systems in response to various stimuli, such as ethanol (191), hemedeficiency, viral infection or low levels of double-stranded RNA, amino acid and nutrient
starvation, purine limitation, serum and growth factor deprivation, transient transfection
of certain plasmids, cerebral ischemia, exercise, heat shock, heavy metals, and release of
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calcium from the endoplasmic reticulum (ER) or ER-stress (192). Several eIF2α kinases
have been reported and each of them reponds to different stimuli. These include hemeregulated kinase (HRI) activated by hemin depriviation (193), double-stranded RNAinduced protein kinase (PKR) by ds-RNAnd PACT/Rax (194), GCN2 kinase from yeast
(195), Drosophila and mouse (196;197) by amino acids and sereum starvation, and PKRlike ER kinase (PERK) by ER-stress (198). All these kinases can lead to eIF2α
phophorylation and translation initiation inhibition (199).
2.3

Ethanol and protein synthesis
Protein synthesis is essential to sustain normal cellular functions. Previous studies

have shown that ethanol significantly impairs brain growth (200), by decreasing the
volume, weight and protein content in cerebellum of ethanol-exposed pups (201-203).
Ethanol feeding decreased the rate of protein synthesis in rats’ heart (204), liver (205)
and skeletal muscle (206) by inhibiting peptide-chain initiation. Meanwhile, Wu (207)
found that the protein synthesis inhibition induced by ethanol treatment can be partially
reversed by adding purified eIF2 (included α, β and γ subunits) in rabbit reticulocytes.
The phosphorylation of eIF2α can be increased up to 90% in rat hepatic cells after
ethanol feeding (208). Furthermore, the reduction in protein synthesis induced by ethanol
occurs through inhibition of protein synthesis initiation by blocking the ternary complex
formation among eIF2α, GTP and initiator Met-tRNA rather than alteration in abundance
of aminoacids or ribosomes (209). However no previous work has been done in the
neuronal cells to elucidate whether eIF2α is involved in the mechanism of ethanolinduced protein synthesis inhibition or the signaling pathway that leads to ethanolinduced protein synthesis inhibition.
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Abstract
The causes of sporadic Parkinson’s disease (PD) are poorly understood.

6-

hydroxydopamine (6-OHDA), a PD mimetic, is widely used to model this
neurodegenerative disorder in vitro and in vivo; however, the underlying mechanisms
remain incompletely elucidated.

We demonstrated here that 6-OHDA evoked

endoplasmic reticulum (ER) stress which was characterized by an up-regulation in the
expression of GRP78 and GADD153 (Chop), the cleavage of procaspase-12, and
phosphorylation of eukaryotic initiation factor-2α in human dopaminergic neuronal cell
line (SH-SY5Y) and cultured rat cerebellar granule neurons (CGNs). Glycogen synthase
kinase-3β (GSK3β) responds to ER stress and its activity is regulated by phosphorylation.
6-OHDA significantly inhibited phosphorylation of GSK3β at Ser9, whereas it induced
hyperphosphorylation of Tyr216 with little effect on GSK3β expression in SH-SY5Y
cells and PC12 cells (a rat dopamine cell line), as well as CGNs. Furthermore, 6-OHDA
decreased the expression of cyclin D1, a substrate of GSK3β, and dephosphorylated Akt,
the upstream signaling component of GSK3β. Protein phosphatase 2A (PP2A), an ER
stress-responsive

phosphatase,

was

involved

in

6-OHDA-induced

GSK3β

dephosphorylation (Ser9). Blocking GSK3β activity by selective inhibitors (lithium,
TDZD-8 and L803-mts) prevented 6-OHDA-induced cleavage of caspase-3, poly(ADPribose) polymerase (PARP), DNA fragmentations, and cell death. With a tetracycline
(Tet)-controlled TrkB inducible system, we demonstrated that activation of TrkB in SHSY5Y cells alleviated 6-OHDA-induced GSK3β dephosphorylation (Ser9) and
ameliorated 6-OHDA neurotoxicity. TrkB activation also protected CGNs against 6OHDA-induced damage. On the other hand, antioxidants had little effect on 6-OHDA-
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induced GSK3β activation although they also offered neuroprotection. These results
suggest that GSK3β is a critical intermediate in pro-apoptotic signaling cascades that are
associated with neurodegenerative diseases, thus providing a potential target site
amenable to pharmacological intervention.
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Introduction
The endoplasmic reticulum is an intracellular compartment involved in calcium
signaling and protein folding/processing.

Impaired function of the endoplasmic

reticulum (ER), commonly referred to as ER stress, is usually caused by alterations in
Ca2+ homeostasis, oxidative stress and accumulation of unfolded proteins. ER stress is
now known as an important factor in the neuropathology of a wide variety of
neurological disorders (1-3).

Exemplary among these is Alzheimer’s disease (AD).

Neurotoxic effects of amyloid β-peptides are at least partially targeted to the ER (4, 5).
Recent genetic evidence indicates that ER stress is associated with Parkinson’s disease
(PD) (6, 7).
The molecular mechanisms of most neurodegenerative disorders remain elusive.
For example, although some genetic and environmental factors have been identified as
contributing to certain forms of PD, the etiology of this central nervous system disorder
remains unknown (8, 9). The hallmark of PD is a loss of dopaminergic neurons in the
substantia nigra, which leads to clinical and pharmacological abnormalities characterizing
the disease. The majority of PD is sporadic, and the cause of neuronal death has not been
defined. Recent advances indicate that the excitotoxicity as well as the generation of
reactive oxygen species (ROS) are important mediators of neuronal death in PD (10-12).
It appears that these events involve mitochondrial abnormality. However, downstream
effectors in the death pathway have not been defined, nor is it clear whether
mitochondrial events are the sole contributors to neuronal death in PD and other
neurodegenerative diseases. Recent studies point to ER stress as a potential mediator of
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pathogenesis of PD. The research using drug models suggests that PD mimetics induce
ER stress in cultured neurons (13, 14).
Much PD research relies on drug models that mimic the selective dopaminergic
neuron degeneration that occurs in this disorder. Agents widely used for this purpose
include 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-pyridinium (MPP+) and
rotenone. 6-OHDA is a selective catecholaminergic neurotoxin that is widely used to
study mechanisms of cell death in dopaminergic neurons as well as other types of
neurons (13, 15-18).

6-OHDA can be formed from dopamine by non-enzymatic

hydroxylation in the presence of Fe2+ and H2O2 (19). Endogenous 6-OHDA was detected
in the brain and urine samples of patients suffering from PD (20-22), suggesting that this
compound is involved in the pathogenesis of PD.

The cellular and molecular

mechanisms by which 6-OHDA induces neuronal loss, however, are not clear. Human
dopaminergic neuronal cell line SH-SY5Y possesses many qualities of substantia nigra
neurons (23), and is therefore widely used to study the death of dopaminergic neurons.
In the present study, we demonstrate that 6-OHDA induces ER stress in SH-SY5Y cells,
and subsequently activates glycogen synthase kinase 3β (GSK3β), an ER stressresponsive component. Furthermore, our study reveals that GSK3β plays a critical role in
6-OHDA-induced death of neuronal cells.
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Materials and Methods
Materials
Tetracycline (Tet), thapsigargin (Tha), tunicamycin (Tun), LiCl, okadaic acid
(OA), N-acetylcysteine (NAC), tert-butylhydroquinone (tBHQ) and 6-hydroxydopamine
(6-OHDA) were obtained from Sigma Chemical Co. (St Louis, MO).

All of the

antibodies except anti-actin and anti-p-GSK3β (Tyr216) were obtained from Cell
Signaling Technology, Inc. (Beverly, MA). The anti-actin antibody was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA) and the anti-p-GSK3β (Tyr216) antibody
was obtained from Oncogene Research Products (San Diego, CA). Inhibitors of GSK3β
(TDZD-8; L803-mts), glutathione monoethyl ester (GSH-MEE), Trolox (a derivative of
vitamin E) and (–)-Epigallocatechin gallate (EGCG) were purchased from Calbiochem
(La Jolla, CA).
Cell culture and treatment
SH-SY5Y cells and PC12 cells were obtained from ATCC. SH-SY5Y cells were
grown in Eagle’s MEM containing 10% fetal bovine serum (FBS), 2 mM L-glutamine
and 25 µg/ml gentamicin at 37°C with 5% CO2. PC12 cells were maintained in RPMI1640 medium containing 5% FBS, 10% horse serum, 100 units/ml penicillin and 100
µg/ml streptomycin. SH-SY5Y cells expressing inducible TrkB (TB3 and TB8 cells)
were generated under the control of a Tet-repressible promoter element (24). TrkB is a
high affinity receptor for brain derived neurotrophic factor (BDNF).

Culture and

treatment of TB3 and TB8 cells were previously described (24).
Cerebellar granule neurons (CGNs) were also selected for this study because 6OHDA induces apoptosis in these neurons (17, 25-27). Cultures of CGNs were created

36

using a previously described method (28, 29). Sprague Dawley rats were obtained from
Hilltop Laboratory Inc. (Scottdale, PA). Briefly, cerebella were obtained from 7-day-old
rat pups, minced with a sterile razor blade, and suspended in 10 ml of trypsin solution
(0.025%) at 37°C. After incubation for 15 min, an equal volume of solution containing
DNAse (130 Knuitz units/ml) and trypsin inhibitor (0.75 mg/ml) were added and the
tissue was sedimented by a brief (5 seconds) centrifugation. The tissue was dissociated
by trituration, and the cell suspension was centrifuged through a 4% bovine serum
albumin solution. The cell pellet was re-suspended in Eagle’s MEM containing the
following supplements: 10% FBS, 25 mM KCl, 1 mM glutamine, 33 mM glucose, and
penicillin (100 units/ml)/streptomycin (100 µg/ml). Cells (seeding density of 3.2-6.4 x
104/cm2) were plated into poly-D-lysine (PDL, 50 µg/ml)-coated culture wells or dishes.
Cells were incubated at 37ºC in a humidified environment containing 5% CO2 for at
least 24 hours before initiating 6-OHDA treatment. For blocking GSK3β activity, cells
were treated with LiCl (222), TDZD-8 (10 µM) or L803-mts (5-20 µM) for 30-60
minutes prior to 6-OHDA exposure.

Cell viability
MTT assay: The MTT assay was employed to determine the number of viable
cells in culture (Roche Molecular Biochemicals. Indianapolis, IN) as previously
described (30). The assay is based on the cleavage of the yellow tetrazolium salt MTT
[3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide] to purple formazan
crystals by metabolically active cells.

Briefly, the cells were plated into 96-well

microtiter plates and exposed to 6-OHDA (0 or 50 µM) for 48 h. Following 6-OHDA
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exposure, 10 µl of MTT labeling reagent were added to each well and the plates were
incubated at 37ºC for 4 h. The cultures were then solubilized and spectrophotometric
absorbance of the samples was detected by a microtiter plate reader. The wavelength to
measure absorbance of formazan product is 570 nm, with a reference wavelength of 750
nm.

Apoptosis assay
Accumulation of DNA fragments in the cytoplasm of apoptotic cells was
determined by ELISA (Roche Molecular Biochemicals). We have demonstrated that this
measurement was sensitive to quantify neuronal apoptosis and was consistent with other
morphometric indices of apoptosis (29, 31). Briefly, the cells were maintained in 96-well
plates. After treatment, the cultures were washed twice with 0.01 M PBS, and the
cultured cells were lysed. Twenty microliters of cell lysate from each well were mixed
with 80 µl of antibody solution in the coated wells. The loaded wells were incubated at
room temperature for 2 h. Substrate was added to each well after it was washed three
times in incubation buffer. After incubation at room temperature for 10-20 min, the
optical density was measured using a microtiter plate reader with a light filter of 405 nm.
The readings were used to measure the degree of apoptosis.

Northern blot analysis
Total RNA was extracted from TB3 and TB8 cells cultured in either Tet-on or
Tet-off conditions.

RNA isolation and hybridization were performed as described

previously (32). Thirty µg of total RNA for TrkB was eletrophoresed in 1.2% agarose-
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6% formaldehyde gels.

Gels were stained with 2 mg/ml ethidium bromide.

Hybridization was performed with
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P-labeled insert DNA isolated from a plasmid

containing TrkB (33).

Immunoblotting
The immunoblotting procedure for detecting phosphorylation and expression of
signal proteins was performed as previously described (34). Briefly, cells were washed
with PBS and lysed with RIPA buffer for 10 minutes, solubilized cells were centrifuged,
the supernatant was collected, and the protein concentration was determined. Aliquots of
the protein (40 µg) were loaded onto the lanes of a sodium dodecylsulfate (SDS) 10%
polyacrylamide gel. The proteins were separated by electrophoresis, and the separated
proteins were transferred to nitrocellulose membranes. The membranes were blocked
with either 5% nonfat dry milk or 5.0% BSA (for detection of phosphorylation) in 10 mM
phosphate-buffered saline (pH 7.4) and 0.05% Tween-20 (TPBS) at room temperature for
one hour to block non-specific immunoreactivity. Subsequently, the membranes were
incubated with primary antibodies directed against signaling proteins for 2 hours at room
temperature or overnight at 4ºC. After two quick washes in TPBS, the membranes were
incubated with a secondary antibody conjugated to horseradish peroxidase (Amersham,
Arlington Hts. IL) diluted at 1:2000 in TPBS for 1 hour. The immune complexes were
detected by the enhanced chemiluminescence method (Amersham). In some cases, the
blots were stripped and re-probed with an anti-actin antibody.

Statistical analysis
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Differences among treatment groups were tested using analysis of variance
(ANOVA). Differences in which p was less than 0.05 were considered statistically
significant.

In cases where significant differences were detected, specific post-hoc

comparisons between treatment groups were examined with Student-Newman-Keuls
tests.
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Results
6-OHDA induces endoplasmic reticulum (ER) stress and apoptosis
ER stress, which is triggered by the loss of calcium homeostasis or an
accumulation of unfolded/misfolded proteins in the ER lumen, is generally characterized
by up-regulation of GRP78 and GADD153, phosphorylation of eukaryotic initiation
factor-2 alpha (eIF2α) and cleavage of ER-specific procaspase-12 (5, 35-38). 6-OHDA
exposure caused a significant increase in the expression of GRP78, GADD153 and the
phosphorylation of eIF2α at Ser51 in SH-SY5Y cells (Fig. 2.1A), indicating the
occurrence of ER stress. Similarly, we observed a significant up-regulation of GRP78
and GADD153, phosphorylation of eIF2α, and cleavage of procaspase-12 in primary
cultures of cerebellar granule neurons (CGNs) (Fig. 2.1B).

Thapsigargin and

tunicamycin are the most widely applied agents to experimentally induce ER stress (39,
40). Thapsigargin inhibits ER-associated Ca2+-ATPase and disrupts Ca2+ homeostasis
(41). On the other hand, tunicamycin is known to specifically inhibit N-glycosylation in
the ER (5). As positive controls, these ER stress inducers up-regulated expression of
GRP78 and GADD153, phosphorylation of eIF2α, and cleavage of procapase-12 (data
not shown). Furthermore, 6-OHDA exposure decreased cell number regardless of serum
content in the medium (Fig. 2.2A and 2.2B). It was noted that 6-OHDA induced a
decrease in cell number in the serum-containing medium which became more evident
than in serum-free medium after day 2. It is known that GSK3β activation can cause
suppression of cell proliferation in addition to cell death.

SH-SY5Y cells were

proliferating in serum-containing medium, but not in serum-free medium. It was likely
the more severe reduction of cell number that occurred in serum-containing medium was
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a combined effect of 6-OHDA on cell proliferation and cell death. Therefore, serum-free
medium was selected for all subsequent experiments to eliminate the confounding effect
of cell proliferation. The alteration in cell number was accompanied by an increase in
apoptosis that was quantified by DNA fragmentation (Fig. 2.2C). 6-OHDA-induced
apoptosis was further verified by the evidence of caspase-3 activation and cleavage of
poly(ADP-ribose) polymerase (PARP) (Fig. 2.2D). Thapsigargin and tunicamycin also
induced apoptosis of SH-SY5Y cells to an extent similar to that caused by 6-OHDA (Fig.
2.2B and 2.2C).

6-OHDA activates GSK3β
GSK3β is a kinase that plays a pivotal role in numerous cellular functions ranging
from glycogen metabolism and modulation of microtubule dynamics to the regulation of
cell survival (42, 43). A recent study indicates that ER stress may activate GSK3β by
inducing dephosphorylation at Ser9 (39). Since 6-OHDA induced ER stress, we sought
to determine whether 6-OHDA could regulate GSK3β phosphorylation. The activity of
GSK3β is regulated negatively by the phosphorylation of serine 9 (Ser9) and positively
by the phosphorylation of tyrosine 216 (Tyr216) (43). As shown in Fig. 2.3A, 6-OHDA
inhibited phosphorylation of GSK3β at Ser9, whereas it stimulated phosphorylation at
Tyr216 in SH-SY5Y cells.

The effect of 6-OHDA on GSK3β phosphorylation

diminished after 24 h of exposure. 6-OHDA had little effect on the expression of
GSK3β.

PC12 cells are a rat dopamine cell line that has been extensively used for

studying the mechanism of PD mimetic–induced damage. As shown in Fig. 2.3B, 6OHDA also induced dephosphorylation of GSK3β at Ser9 without affecting its
expression levels in PC12 cells. Similarly, 6-OHDA-mediated dephosphorylation of
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GSK3β at Ser9 was observed in cultured CGNs (Fig. 2.3C). Akt is one of the most
important upstream signaling components that regulate GSK3β phosphorylation at Ser9
(43). 6-OHDA also induced a transient inhibition of Akt phosphorylation at Ser473 in
SH-SY5Y cells, PC12 cells and CGNs (Fig. 2.3). Cyclin D1 is a substrate of GSK3β;
phosphorylation of cyclin D1 by GSK3β facilitates an ubiquitin-dependent degradation of
cyclin D1 (44, 45). 6-OHDA down-regulated cyclin D1 in SH-SY5Y cells and PC12
cells (Fig. 2.3D), indicating the activation of GSK3β. For a comparison, two ER stress
inducers (thapsigargin and tunicamycin), also dephosphorylated GSK3β at Ser9 in a
similar pattern (Fig. 2.3E). It has been demonstrated that ER stress-induced GSK3β
dephosphorylation (Ser9) is mediated by PP2A in SH-SY5Y cells (39). We sought to
determine whether PP2A was involved in 6-OHDA-mediated GSK3β dephosphorylation.
As shown in Fig. 2.4, blocking PP2A activity by okadaic acid (1 nM) eliminated 6OHDA-mediated GSK3β dephosporylation (Ser9). At concentrations less than 5 nM,
okadaic acid specifically blocks PP2A activity without affecting PP1 (46).

6-OHDA-induced cell death is mediated by GSK3β.
It has been recently recognized that GSK3β is an important modulator of
apoptosis (42, 43). To determine whether 6-OHDA-induced neuronal apoptosis was
mediated by GSK3β, we blocked GSK3β activity by pre-incubating SH-SY5Y cells with
lithium, a widely used selective GSK3β inhibitor (47), or a synthetic chemical GSK3β
inhibitor (TDZD-8). TDZD-8 has been shown to specifically inhibit GSK3β activity with
little effect on other kinases (47). After pre-treatment with GSK3β inhibitors, SH-SY5Y
cells were exposed to 6-OHDA and cell death was evaluated. As shown in Figs. 2.5A
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and 2.5B, pretreatment with TDZD-8 eliminated 6-OHDA-induced cell death as
measured by cell viability (MTT assay) and apoptosis (DNA fragmentation ELISA).
Lithium also significantly rescued SH-SY5Y cells from 6-OHDA-induced cell death.
Furthermore, TDZD-8 and lithium blocked 6-OHDA-mediated caspase-3 activation and
cleavage of PARP (Fig. 2.5C), which confirmed the neuroprotective effect of GSK3β
inhibitors. Similarly, neuroprotection by TDZD-8 and lithium against 6-OHDA-induced
damage was observed in cultured CGNs (Fig. 2.5D). Involvement of GSK3β in 6OHDA-induced cell death was further verified using a novel cell-permeable peptide
inhibitor of GSK3β (L803-mts).

L803-mts is a substrate-specific, competitive

phosphorylated peptide inhibitor of GSK3β. This inhibitor is shown to selectively block
GSK3β activity without affecting the activity of other kinases (48).

L803-mts

significantly protected SH-SY5Y and PC12 cells against 6-OHDA-induced cell death in a
concentration dependent manner (Fig. 2.5E). Only 5 and 10 µM were used in SH-SY5Y
cells because L803-mts was cytotoxic for these cells at the concentrations ≥ 20 µM.
L803-mts blocked 6-OHDA-induced down-regulation of cyclin D1 (Fig. 2.5F), indicating
that this peptide effectively inhibited GSK3β activity.

TrkB activation induces GSK3β phosphorylation and protects neuronal cells from 6OHDA-induced death
The survival, differentiation and function of neurons are regulated by a family of
growth factors called neurotrophins (NTs), which includes nervous growth factor (NGF),
brain derived neurotrophic factor (BDNF), NT-3 and NT-4/5 (49). The effects of NTs
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are mediated by the tyrosine kinase receptor of the Trk family at the cytoplasmic
membrane (TrkA, TrkB and TrkC). BDNF binds to TrkB and initiates a number of antiapoptotic signaling pathways including phosphatidylinositol 3-kinase (PI3K)/Akt
pathway (24, 49, 50). Activated Akt promotes GSK3β phosphorylation at Ser9 resulting
in its inhibition (43). SH-SY5Y cells express low levels of TrkB and barely respond to
BDNF. With a Tet-regulated inducible TrkB expression system (TB8 and TB3 cells), we
were able to determine whether TrkB activation can override 6-OHDA-mediated GSK3β
dephosphorylation (Ser9) and provide protection against 6-OHDA-induced cell death. In
the Tet-off condition (no Tet in culture medium), TrkB expression was induced in both
TB8 and TB3 cells (derivatives of SH-SY5Y cells)(Fig. 2.6A). Activation of TrkB by
BDNF in Tet-off TB8 cells induced phosphorylation of GSK3β at Ser9, which
presumably inhibits the activation of GSK3β (Fig. 2.6B). Furthermore, BDNF alleviated
6-OHDA-induced GSK3β dephosphorylation (Ser9) in TB8 cells expressing high TrkB
(Tet-off condition, Fig. 2.6C), but not in a Tet-on condition (data not shown). More
importantly, BDNF significantly ameliorated 6-OHDA-induced cell death in Tet-off TB8
cells; however, it was ineffective at protecting TB8 cells in a Tet-on condition (Figs.
2.7A and 2.7B).

A similar result was observed with TB3 cells (data not shown).

Similarly, BDNF significantly protected CGNs from 6-OHDA-induced cell death (Fig.
2.5D); these cells are known to express TrkB, but not TrkA (51). 6-OHDA neurotoxicity
may be mediated by oxidative stress.

To determine whether oxidative stress was

involved in 6-OHDA-induced GSK3β activation, we examined the effect of various
antioxidants on 6-OHDA-induced cell death and GSK3β activation. As shown in Fig.
2.8A, these antioxidants offered significant neuroprotection against 6-OHDA-induced
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cell death. However, none of these antioxidants significantly affected 6-OHDA-mediated
GSK3β dephosphorylation (Ser9). Results obtained from the treatment of NAC and
GSH-MEE are presented (Fig. 2.8B).
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Discussion
The mimetics of Parkinson’s disease (PD), such as 6-hydroxydopamine (6OHDA), 1-methyl-4-phenyl-pyridinium (MPP+) and rotenone have been widely used to
model this neurodegenerative disorder.

However, the mechanisms mediating their

activation of a neurodegenerating program remain incompletely elucidated.

We

demonstrate here that 6-OHDA, a PD mimetic, causes ER stress which is characterized
by increase in ER chaperones and the phosphorylation of eIF2α. 6-OHDA induces cell
death and activates apoptotic signaling, such as caspase-3 activation and cleavage of
PARP. These findings are supported by recent studies which show PD mimetics could
induce unfolded protein response (UPR) and the expression of genes involved in ER
stress response (13, 14). More importantly, our study reveals that glycogen synthase
kinase 3β (GSK3β) is a key intermediate for 6-OHDA-triggered apoptotic signaling;
blocking GSK3β activity by selective inhibitors or by activation of TrkB eliminates 6OHDA-mediated caspase-3 activation, cleavage of PARP and DNA fragmentation.
GSK3, a serine/threonine kinase originally identified as a regulator of glycogen
metabolism, is also a central component of the Wnt signaling pathway important for
proper axis formation during embryonic development (52).

There are two highly

homologous forms of GSK3 in mammals, GSK3α and GSK3β. GSK3β is particularly
abundant in the central nervous system, where it is localized primarily in neurons (53).
Recent studies indicate that cellular stress, such as ER stress, oxidative stress, heat shock
and hyperosmotic stress, can modulate the activity of GSK3β (39, 43, 54). GSK3 is
unusual in that it appears to be largely regulated by inhibition. One mean by which
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GSK3β can be inactivated is through phosphorylation of Ser9. Numerous kinases, such
as Akt/protein kinase B (PKB), protein kinase C (PKC), p70 S6 kinase, p90Rsk and
protein kinase A (PKA) can phosphorylate GSK3β at Ser9 and therefore inactivate
GSK3β (42, 43). GSK3β is also capable of being regulated by an activation pathway.
Activation of GSK3β is accomplished by phosphorylation at Tyr216; research on
mechanisms of phosphorylation of GSK3β at Tyr216 is relatively sparse. Available
evidence indicates that phosphorylation at Tyr216 can be regulated by alterations in
intracellular calcium levels or by Fyn, a member of the Src tyrosine kinase family (55,
56).
Our study shows that 6-OHDA induces GSK3β dephosphorylation (Ser9). It has
been reported that cellular stress, such as ER stress or hyperosmotic stress, can activate
protein phosphatase 2A and 2B (PP2A and PP2B) (39, 46, 54). PP2A is known to
dephosphorylate Akt and GSK3β at Ser9 (57-59). Induction of ER stress by thapsigargin
and tunicamycin dephosphorylates GSK3β at Ser9; blocking PP2A activation eliminates
ER stress-mediated dephosphorylation (39). Similarly, our results show that blockage of
PP2A abolishes 6-OHDA-induced GSK3β dephosphorylation, suggesting that the
alteration in GSK3β phosphorylation results from ER stress. 6-OHDA increases GSK3β
phosphorylation at Tyr216; this may involve an alteration in the intracellular calcium
concentration since it has been shown that 6-OHDA can change the expression of
calcium binding proteins and disrupt intracellular calcium homeostasis (60-62).

As

mentioned above, calcium homeostasis is a key mediator of GSK3β phosphorylation at
Tyr216 (55).
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The ER is an intracellular compartment that plays an important role in the
maintenance of Ca2+ homeostasis and proper folding of newly synthesized membranous
and secretory proteins (2).

Conditions associated with ER dysfunction induce highly

conserved stress responses. These include the unfolded protein response (UPR), the ER
overloaded response (EOR) and the ER-associated degradation (ERAD) (63).
Accumulating evidence indicates that ER stress may be a common denominator for acute
brain injury (e.g., cerebral ischemia) and chronic degenerative diseases (e.g. Alzheimer’s
disease and Parkinson’s disease) (2, 42). However, the mechanisms underlying ER
stress-triggered neurodegeneration are unclear. We demonstrate that dopaminergic cells
(SH-SY5Y and PC12 cells) and glutamatergic neurons (cerebellar granule neurons)
display a similar response to 6-OHDA, suggesting that 6-OHDA-evoked ER-stress and
the activation of GSK3β may not be restricted to dopaminergic neurons. It has been
suggested that 6-OHDA-evoked neuronal apoptosis is independent of cell type and does
not require a dopamine transporter (64). More importantly, our results link PD mimeticevoked ER stress to GSK3β activation, providing an important insight into the
relationship between ER stress and degenerative diseases.
A growing body of evidence suggests that GSK3β is an important modulator of
apoptosis. It appears that GSK3β activity correlates inversely with neuronal viability (39,
65-67). For example, over-expression of GSK3β in specific regions of the brain in adult
mice results in neuronal death in these regions (67). Neuronal apoptosis induced by
trophic withdrawal also appears mediated by GSK3β activation (66). GSK3β has been
directly linked to several key neuropathological mechanisms of Alzheimer’s disease
(AD) (42, 68). The mechanisms by which GSK3β facilitates apoptosis have yet to be
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identified. GSK3β has a broad spectrum of substrates. One, and perhaps the most
important mechanism, is that it inhibits activation of many transcription factors. Several
transcription factors that are known targets of GSK3β regulate cell survival. These
include NFAT, HSF-1, CREB, AP-1 and NF-кB (42, 43). Furthermore, recent evidence
suggests that subcellular redistribution of GSK3β to the nucleus may also trigger a
proapoptotic signaling cascade (69).
Under physiological conditions, 6-OHDA can be oxidized to generate reactive
oxygen species (ROS) and many neurotoxic effects of 6-OHDA are believed to be
mediated by oxidative stress (70-75). Various antioxidants, such as NAC, tBHQ, GSH,
EGCG, have been previously shown to protect neuronal cells against 6-OHDA-induced
cell death (71-75). Consistent with these findings, we show here that antioxidants offer
significant neuroprotection; however, these antioxidants have little effect on 6-OHDAmediated GSK3β dephosphorylation.

This result suggests that oxidative stress is

minimally involved in the ER stress-GSK3β pathway.
Selective GSK3β inhibitors eliminate 6-OHDA neurotoxicity in these neuronal
cells, indicating that GSK3β is a key component of the proapoptotic signaling cascade.
Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF) and
brain-derived neurotrophic factor (BDNF), are promising agents for neuroprotective
therapies. The GDNF receptor is distributed in the substantia nigra (SN) neurons, and its
neuroprotective action is mainly mediated by the PI3K/Akt pathway (76-79). A recent
study demonstrates that GDNF significantly mitigates 6-OHDA-induced chromatin
condensation and DNA fragmentation in a dopaminergic MN9D cell line; the
neuroprotection is mediated by the PI3K/Akt pathway (79). Akt is up-stream of GSK3β,
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and its activation results in an inhibition of GSK3β. It is likely, therefore, that GSK3β is
involved in GDNF-mediated neuroprotection. Neurotrophin receptors (TrkA, TrkB and
TrkC) regulate neuronal survival; activation of TrkB causes enhanced Akt activity (24,
80-82). TrkB is expressed in the SN neurons (83, 84). The activation of TrkB is shown
to promote the survival of the SN neurons and protect the SN neurons against excitotoxic
insult (85, 86). Our results show that activation of TrkB can override 6-OHDA-mediated
GSK3β dephosphorylation (Ser9) and protect neurons against 6-OHDA-induced damage.
These results suggest that neuroprotection provided by growth factors/neurotrophins or
GSK3β inhibitors may share the same mechanism, that is, the modulation of a common
intermediate, GSK3β.

Therefore, the development of selective and safe GSK3β

inhibitors may provide a therapeutic benefit in alleviating or slowing down the
progression of neurodegeneration.
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Figures
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Figure 2. 1 6-OHDA-induced ER stress
(A) SH-SY5Y cells were cultured in serum-free medium for 24 h. Cells were exposed
to 6-OHDA (0 or 50 µM). The expression of GRP78, GADD153 and phosphorylation of
eIF2α (Ser51) were determined by immunoblots. (B) CGNs were isolated from 7-dayold rat pups, maintained in serum-free medium and exposed to 6-OHDA (50 µM). The
expression of GRP78, GADD153, procaspase-12 and phosphorylation of eIF2α were
determined by immunoblots. The experiment was replicated three times.
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Figure 2. 2 6-OHDA-induced apoptosis of SH-SY5Y cells
(A) Cells were exposed to 6-OHDA (0 or 50 µM) and the number of viable cells was
determined by MTT assay as described under the Materials and Methods. 6-OHDAmediated alterations were expressed as a percentage of the control. (B) Cells were
exposed to 6-OHDA (DA, 50 µM), thapsigargin (Tha, 1 µM) and tunicamycin (Tun, 3
µg/ml) for 30 h and a relative number of viable cells was determined. Each data point
represents the mean ± SEM of five replications. * p < 0.05, statistically significant
differences between the controls and 6-OHDA- or Tha/Tun-treated cultures.

(C)

Quantification of apoptosis with DNA fragmentation ELISA. Cells were exposed to 6OHDA (DA, 50 µM), thapsigargin (Tha, 1 µM) and tunicamycin (Tun, 3 µg/ml) for 30 h.
Relative apoptosis was determined with DNA fragmentation ELISA as described under
the Materials and Methods.

Each data point represents the mean ± SEM of four

replications. * p < 0.05, statistically significant differences between the controls and 6OHDA- or Tha/Tun-treated cultures. (D) Activation of caspase-3 and cleavage of PARP.
Cells were exposed to 6-OHDA (50 µM) and the expression of active (cleaved) caspase-3
and PARP was determined with immunoblots.
times.

55

The experiment was replicated three

A

D

C

D C

E

Dd

D

56

DD

57

Figure 2. 3 Effect of 6-OHDA on GSK3β, Akt and Cyclin D1

(A) SH-SY5Y cells were cultured in serum-free medium for 24 h and exposed to 6OHDA (50 µM). Phosphorylation and expression of GSK3β and Akt were determined
by immunoblots. The same blots were stripped and re-probed with an anti-actin antibody
(Panel on the left). The relative amount of phosphorylated proteins imaged on the films
was measured microdensitometrically using SigmaGel software (SPSS, Chicago IL)
(Panel on the right). Each data point (± SEM; bars) is the mean of three replicates. (B)
PC12 cells were cultured in serum-free medium for 24 h and exposed to 6-OHDA (50
µM). The phosphorylation and expression of GSK3β and Akt were determined by
immunoblots. (C) Cerebellar granule neurons (CGNs) were isolated from 7-day-old rat
pups, maintained in serum-free medium and exposed to 6-OHDA (50 µM).
Phosphorylation and expression of GSK3β and Akt were determined by immunoblots.
(D) SH-SY5Y and PC12 cells were cultured in serum-free medium for 24 h and exposed
to 6-OHDA (50 µM). The expression of cyclin D1 was determined by immunoblots.
The same blots were stripped and re-probed with an anti-actin antibody. The experiment
was replicated three times. (E) SH-SY5Y and PC12 cells were treated with thapsigargin
(Tha, 1 µM) or tunicamycin (Tun, 3 µg/ml) for 1-12 h. Phosphorylation (Ser9) and
expression of GSK3β were determined by immunoblots. The experiment was replicated
three times.
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Figure 2. 4

Effect of inhibitor of PP2A/PP1 on 6-OHDA-mediated GSK3β

dephosphorylation
SH-SY5Y cells were cultured in serum-free medium and pre-treated with a selective
inhibitor of PP2A/PP1, okadaic acid (OA, 0 or 1 nM), for 30 min. After that, cells were
exposed to 6-OHDA (50 µM), and phosphorylation of GSK3β (Ser9) was determined by
immunoblots. The same blots were stripped and re-probed with an anti-actin antibody
(Top panel). The relative amount of phosphorylated proteins imaged on the films was
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measured microdensitometrically (Bottom panel). The experiment was replicated three
times.
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Figure 2. 5 Effect of inhibitors of GSK3β on 6-OHDA-mediated cell death

(A) SH-SY5Y cells were cultured in serum-free medium and pre-treated with inhibitors
of GSK3β, LiCl (Li, 20 mM) or TDZD-8 (10 µM) for 1 h. After that, cells were exposed
to 6-OHDA (DA, 50 µM, 24 h) and the numbers of viable cells were determined by the
MTT assay. The amount of cells relative to the untreated control was calculated. (B)
SH-SY5Y cells were similarly treated as described in (A) and relative apoptosis was
determined as described in Figure 1.2. Each data point (± SEM; bars) is the mean of four
independent trials. * p < 0.05, statistically significant difference from untreated controls.
(C) Expression of PARP and active (cleaved) caspase-3. SH-SY5Y cells were similarly
treated as described in (A) and the expression of PARP and active caspase-3 was
determined as described in Figure 1.2. The experiment was replicated three times. (D)
CGNs were pretreated with BDNF (100 ng/ml, 24 h) or inhibitors for GSK3β (Li or
TDZD-8, 1h). After that, cells were exposed to 6-OHDA (50 µM) for 24 h. The number
of viable cells was determined with MTT assay and the amount of cells relative to the
untreated control was calculated. Each data point (± SEM; bars) is the mean of four
independent trials. * p < 0.05, statistically significant difference from untreated controls.
** p < 0.05, statistically significant difference from 6-OHDA-treated groups. (E) SHSY5Y and PC12 cells were cultured in serum-free medium and pre-treated with a cellpermeable peptide inhibitor of GSK3β (L803-mts, 0-20 µM) for 1 h. After that, cells
were exposed to 6-OHDA (50 µM) and the number of viable cells was determined by
MTT assay. Each data point (± SEM; bars) is the mean of four independent trials. * p <
0.05, statistically significant difference from 6-OHDA only groups. (F) SH-SY5Y cells
were pre-treated with L803-mts (0 or 15 µM) for 1 h, and exposed to 6-OHDA (50 µM).
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The expression of cyclin D1 was determined by immunoblots (Top panel). The same
blots were stripped and re-probed with an anti-actin antibody. The relative amount of
cyclin D1 was measured microdensitometrically and normalized to the expression of
actin (Bottom panel). The experiment was replicated three times.
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Figure 2. 6 BDNF-induced GSK3β phosphorylation in SH-SY5Y cells

(A) Inducible expression of TrkB in SH-SY5Y cells. TB8 and TB3 cells were cultured
for 3 days in the presence or absence of Tet (1 µg) in a medium containing 10% FBS.
Total RNA was extracted, and 30 µg of total RNA was electrophoresed in a 1.2%
agarose/formaldehyde gel and stained with 2 mg/ml ethidium bromide.

Gels were

subsequently transferred to a nitrocellulose membrane, and hybridized with a 32P-labeled
cDNA probe for TrkB. (B) BDNF induced phosphorylation of GSK3β at Ser9. TB8
cells expressing high levels of TrkB (Tet-off condition) were cultured in serum-free
medium and exposed to BDNF (100 ng/ml). Phosphorylation and expression of GSK3β
were determined with immunoblots. The same blots were stripped and re-probed with an
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anti-actin antibody.

(C) Counteracting 6-OHDA’s effect by BDNF.

TB8 cells

maintained in a Tet-off condition were pre-treated with BDNF (0 or 100 ng/ml) for 24 h.
After pre-treatment, cells were exposed to 6-OHDA (50 µM) with/without BDNF for 2 h.
Phosphorylation and expression of GSK3β were determined by immunoblots.
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Figure 2. 7 Effect of TrkB activation on 6-OHDA-mediated cell death

TB8 cells were cultured for 3 days in the presence or absence of Tet (Tet-on or Tet-off, 1
µg). Cells were then pre-treated with BDNF (0 or 100 ng/ml) for 24 h and exposed to 6OHDA (DA, 50 µM) for an additional 24 h. Relative apoptosis (A) and the number of
viable cells (B) were determined as described in Figure 2. Each data point (± SEM; bars)
is the mean of four independent trials. * p < 0.05, statistically significant difference from
paired, untreated controls.
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Figure 2. 8

Effect of antioxidants on 6-OHDA-induced cell death and GSK3β

dephosphorylation
(A) SH-SY5Y cells grown in serum-free medium were pre-treated with various
antioxidants for 30 min, and exposed to 6-OHDA (50 µM) for 24 h. Cell viability was
analyzed with MTT assay. The experiment was replicated four times. * p < 0.05,
statistically significant difference from 6-OHDA-treated but no antioxidant-exposed
groups. ** p < 0.05, statistically significant difference from paired, antioxidant-treated
but no 6-OHDA-exposed groups.

NAC (N-acetylcysteine, 10 mM); GSH-MEE

(glutathione monoethyl ester, 8 mM); tBHQ (tert-butylhydroquinone, 40 µM); Trolox (10
µM); EGCG [(–)-Epigallocatechin gallate, 1 µM]; Ct (control, ddH2O). (B, C) SH-SY5Y
cells grown in serum-free medium were pre-treated with NAC (223) or GSH-MEE (8
mM) for 30 min, and exposed to 6-OHDA (50 µM).

Phosphorylation (Ser9) and

expression of GSK3β were determined by immunoblots. The experiment was replicated
three times.
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Chapter Three: The Mechanism of Ethanol-induced Protein Synthesis
Inhibition in Cerebellar Granule Cells
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Abstract

Early developmental exposure to ethanol causes profound damage to the
cerebellum, specifically significant reduction in cerebellar volume, weight and protein
content. PACT (Rax) / PKR / eIF2α is an important signal transducting pathway which
controls the protein synthesis initiation response to different stimuli. Previous studies
have shown that ethanol exposure decreases the protein content in rat cerebellum and
inhibits protein synthesis initiation in rat heart, liver and skeletal muscle. Here we
demonstrate that the expressions of PACT (Rax) / PKR / eIF2α are developmentally
regulated in rat cerebellum as ethanol exposure promotes the association of PACT (Rax)
with PKR. Ethanol-induced interaction between PACT (Rax) and PKR leads to
phosphorylation of eIF2α and protein synthesis initiation inhibition. This inhibition can
be enhanced by the over-expression of PACT (Rax). The effect of ethanol can be
reversed by a mutated PACT (Rax) gene at serine 18 or PKR inhibitors. Our results
provide a novel insight into the molecular mechanism for ethanol toxicity.
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Introduction

Ethanol is wildly known as a teratogen (1-3); early exposure to ethanol will cause
a variety of behavioral and neural abnormalities (4-6). In some cases of pregnant women,
heavy chronic ethanol consumption during fetus central nervous system (CNS) causes
fetal alcohol syndrome (FAS) characterized by microcephaly (7), facial dysmorphology
(8), growth retardation (9) and a number of CNS abnormalities (10-12) in newborns. The
developing cerebellum is one of the most vulnerable regions to ethanol in both humans
and animals (13;14). Numerous animal model systems have been used to characterize this
kind of CNS abnormality. One of these studies showed that growth of the rat brain, but
not body growth, was decreased and the cerebellar was inhibited twice as much compared
with the rest of the brain after exposure to ethanol (15). Other studies showed that ethanol
exposure in rat pups led to significant reduction in cerebellar volume, weight (16) and
protein content (17). The molecular mechanism(s) for ethanol’s involvement in decreased
cerebellum size and inhibition of protein synthesis has not been fully elucidated.
Previous work has determined that ethanol exposure decreased protein synthesis
in rat heart (18;19), liver (20) and skeletal muscle (21), as well as in rabbit reticulocytes
(22). Furthermore, ethanol-induced protein synthesis inhibition occurs by blocking the
ternary complex formation among eIF2α, GTP and initiator Met-tRNA in protein
synthesis initiation, rather than by alterations in availability of amino acids or abundance
of ribosomes (23). The phosphorylation of eIF2α can be increased up to 90% in rat
hepatic cells after ethanol treatment (24). However, the signal transduction pathway(s)
that lead to inhibition of the protein synthesis initiation and eIF2α phosphorylation
remain unclear.
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Double-stranded RNA (dsRNA) activated protein kinase (PKR) is a
serine/threonine protein kinase and is ubiquitously expressed in mammalian cells. It
contains 551 amino acids in humans and 515 in mice (25;26). PKR consists of two
functionally distinct domains: an N-terminal dsRNA binding regulatory domain and the
C-terminal catalytic domain (27-31). PKR is initially identified as an interferon-induced
protein that is activated in virus-infected cells by double-stranded RNA produced during
the virus life cycle (32;33). Recently it has been clear that PKR is a component of signal
transduction pathways mediating important cellular functions such as growth control,
proliferation, differentiation and stress response (34-36). PKR can be activated by
dsRNA, cytokines (37),

growth factor, serum deprivation, bacterial products or

physiochemical stress (38;39). A pair of dsRNA binding motifs located in the N-terminal
domain of PKR act as a sensor to bind dsRNA or protein activators (which themselves
contain dsRNA binding domains) (40). The known protein activators of PKR include
PACT (PKR-activating protein) (41-43) and its mouse homologue Rax (44). PACT/Rax
is also a ubiquitously expressed mammalian protein which is phosphorylated at serine 18
following stress; it heterodimerizes with PKR and activates it in absence of dsRNA (45).
Serine 18 of PACT/Rax is a crucial phosphorylation site for activation of PKR. The
serine 18 mutated PACT/Rax can still associate with PKR, but it loses its kinase activity
(46). Upon dsRNA or PACT/Rax binding, PKR undergoes a conformational change,
which results in dimerization and autophosphorylation at Thr-446 and Thr-451 (47-51).
Once activated, PKR phosphorylates its substrates down stream; the α-subunit of
eukaryotic translation initiation factor-2 (eIF2α) is the main substrate of PKR (52;53).
While PKR can be positively regulated by ds-RNA and PACT/Rax, it can also be
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negatively regulated by its cellular inhibitor, P58, a member of the tetratricopeptide
(TPR) family of proteins (54). P58 is activated upon influenza virus infection (55). It is
capable of inhibiting PKR activation and eIF2α phosphorylation by direct interaction
with PKR, blocking PKR dimerization (56).
The eukaryotic translation initiation factor-2 (eIF2) is required in the first step of
initiation in protein synthesis. It is composed of α-, β- and γ-subunits (57;58). The
function of eIF2α is to mediate the binding of the initiator tRNA and Met-tRNAi, to the
40S-ribosomal subunit as a complex in a GTP-dependent manner (59). When PKR
phosphorylates eIF2α at serine-51, it converts eIF2 from a substrate to an inhibitor of its
guanine nucleotide exchange factor, eIF2B (60). This reduction in recycling of eIF2 by
eIF2B leads to inhibition of translation initiation (61). Phosphorylation of the α-subunit in
eIF2 occurs in cells or in cell-free translational systems in response to various stimuli,
including ethanol (62). The present study is designed to explore the mechanism(s) of
ethanol-induced protein synthesis inhibition in neural systems in vitro and in vivo. Our
results show that ethanol activates eIF2α and leads to protein synthesis inhibition, at least
in part, via PACT/Rax-PKR-eIF2α signal transducting pathway.
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Materials and Methods
Inhibitors

Two kinds of PKR inhibitors were used, 2-Aminopurine (2-Ap) was purchased
from Sigma (St. Louis, MO) and PKR inhibitor was purchased from EMD Biosciences
(Darmstadt, Germany).
Animal surgeries and tissue collection

For non-ethanol treatment: Sprague-Dawley rats were obtained from HarlanSprague-Dawley (Indianapolis, IN, USA). The animals were maintained in a temperature
/ humidity controlled facility with a 12-h light / dark cycle. All animal protocols were
approved by the ACUC of West Virginia University and complied with the NIH
guidelines for animal care and use. The number of animals represented a minimal but
adequate number for statistical analysis. Cerebellar tissues were collected from pups on
the designed postnatal days. Pups were anesthetized by injection of ketamine / xylazine
and decapitated. Their cerebella were harvested by cutting through the cerebellar
peduncles, frozen on dry ice, and stored at -80°C for further processing.
For ethanol treatment: Long-Evans male and female breeders obtained from
Simonsen Laboratory (Gilory, CA) and housed in the PUI vivarium, were placed together
on designated evenings and allowed to mate overnight. Gestational day (GD) 0 was
defined as the first morning that sperm was detected on a vaginal smear after overnight
mating. GD 22 was designated as PD 0, and more than 80% of births occurred on GD
22. Rats born on GD 21 were considered PD 0 the following day and rats born on GD
23 were considered PD 1 on that day. Pups were identified by a code, using a permanent
tattoo on one or more paw, produced by subcutaneous injection of a small amount of
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nontoxic black ink (performed prior to group assignment). Fourteen pups were assigned
to two groups. There were two kinds of treatment in each group, intubated with milk
formula (control treatment) or a solution of 11.33% (v/v) ethanol in milk formula
(ethanol treatment) in a volume of 0.03 ml/g body weight 3 times a day separated by 2
hours. In group-1, eight pups were assigned to ethanol or control treatment (2 males and
2 females each) on postnatal day 9 (PD9). In group-2, six pups were assigned to ethanol
or control treatment (1 male and 2 females each) from PD4-9. After treatment, using the
protocol described, previously collected cerebellum tissues were frozen on dry ice, and
stored at -80°C for further processing.
Cell lines and plasmids
Cell lines:

SH-SY5Y, SK-N-MC neuroblastoma and 293 human kidney cell lines were
obtained from ATCC and grown in EMEM (DMEM for 293) containing 10.0% fetal
bovine serum (FBS), 2.0 mM L-glutamine and streptomycin (100 µg/ml)/penicillin (100
units/ml) at 37°C with 5.0% CO2.
PKR+/+ and PKR-/- mouse embryonic fibroblasts (MEFs) were obtained from
Dennis Baltzis at Lady Davis Institute for Medical Research, McGill University, Quebec,
Canada and maintained in Dulbecco's modified Eagle's medium supplemented with 10%
heat-inactivated fetal bovine serum and penicillin-streptomycin (100 units/ml) at 37°C
with 5.0% CO2.
Rax wild type and mutant plasmid:

HA-tagged Rax constructs with wildtype or S18A mutation (substitute Serine to
Alanine at site 18) were cloned into vector pcDEF3 which utilizes the EF-1α promoter.
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Lipofectamine (Invitrogen) was used to transfect plasmids to SK-N-MC or 293 cells
according to manufacturer’s protocol. Stable clones were selected in G418 (0.6 mg/ml)
and screened by Western blotting with anti-HA antibody.
Primary culture of cerebellar granule cells:

Cultures of cerebellar granule cells (CGCs) were created using a previously
described method (63). Briefly, cerebella were obtained from 7-day-old rat pups, and
minced with a sterile razor blade and suspended in 10.0 ml of trypsin solution (0.025%)
at 37°C. After incubation for 15 min, an equal volume of solution containing DNAse
(130 Knuitz units/ml) and trypsin inhibitor (0.75 mg/ml) was added and the tissue was
sedimented by a brief (5 seconds) centrifugation. The tissue was dissociated by
trituration, and the cell suspension was centrifuged through a 4.0% bovine serum albumin
solution, which is a critical step for increasing neuronal viability. The cell pellet was resuspended in Eagle’s MEM containing the following supplements: 10.0% FBS, 25.0 mM
KCl, 1.0 mM glutamine, 33.0 mM glucose, and penicillin (100.0 units/ml)/streptomycin
(100.0 µg/ml). Cells (seeding density of 3.2-6.4 x 104/cm2) were plated into poly-Dlysine (PDL, 50.0 µg/ml)-coated culture wells or dishes and incubated at 37ºC in a
humidified environment containing 5.0% CO2 for at least 24 hours before initiating
ethanol treatment. Due to ethanol’s volatility, a method utilizing sealed containers was
used to maintain ethanol levels in the cultured medium (64). With this method, ethanol
concentration in the medium can be accurately maintained.
Immunoblots analysis

The immunoblotting procedure for detecting phosphorylation and expression of
signal proteins was performed as previously described (65). For cerebellar tissues, the
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cerebella were homogenized in RIPA buffer [1.0% NP40, 0.5% sodium deoxycholate and
0.1% SDS in 0.01M Phosphate-buffered saline (PBS)] and centrifuged at 10,000×g. The
supernatant was collected. For the cultured cells, cells were washed with PBS and lysed
with RIPA buffer for 10 minutes, solubilized cells were centrifuged, the supernatant was
collected. Protein concentration was determined using Bio-Rad Kit. After that aliquots of
equal amounts of the protein were loaded into the lanes of a sodium dodecylsulfate (SDS)
10.0% polyacrylamide gel. The proteins were separated by electrophoresis, and the
separated proteins were transferred to nitrocellulose membranes. The membranes were
then blocked with either 5.0% nonfat dry milk or 5.0% BSA (for detection of
phosphorylation) in 10 mM phosphate-buffered saline (pH 7.4) and 0.05% Tween-20
(TPBS) at room temperature for one hour to block non-specific immunoreactivity.
Subsequently, the membranes were incubated with primary antibodies directed against
signaling proteins for 1-2 hours at room temperature or overnight at 4ºC. After three
quick washes in TPBS, the membranes were incubated for 1 hour with a secondary
antibody conjugated to horseradish peroxidase (Amersham, Arlington Hts. IL) diluted at
1:2000 in TPBS. The membranes were washed again with TPBS and the immune
complexes were detected by the enhanced chemiluminescence method (Amersham). In
some cases, the blots were stripped and re-probed with an anti-actin antibody. All of the
antibodies except anti-p-eIF2α and anti-p-PKR (Thr451) were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). The anti-p-eIF2α was purchased from Biosource
International (Camarillo, CA), and the anti-p-PKR (Thr451) was obtained from Cell
Signaling technology (Beverly, MA).
Immunoprecipitation
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Immunoprecipitation analysis of protein-protein interaction was performed with a
previously described procedure (66). Briefly, an aliquot of cell lysate containing 200 µg
of protein was incubated with the IP antibody (1:50) overnight at 4°C. Twenty microliters
of protein A/G conjugated to agarose (Santa Cruz Biotech) were added to the lysate, and
the mixture was incubated 3 h at 4°C. Immunoprecipitates were collected by
centrifugation at 10,000×g for 10 min. The pellet was washed three times with 0.5 ml
RIPA buffer [150 mM NaCL, 50 mM Tris (PH 8.0), 1.0% Nonidet P-40, 0.10% SDS,
0.50% deoxycholic acid sodium, 0.10% mg/ml phenylmethylsulfony fluotide, 1.0 mM
sodium orthovanadate, and 3.0% Aprotinin (Sigma)]. Then pellets were resuspended in
20 µl 3× SDS sample buffer and analyzed using the procedures described in the
immunoblt analysis.
Protein synthesis assay

Protein synthesis was measured by incorporation of

14

C labeled amino acids

(Amersham CFB104). Briefly, cells were seeded in 24-well cell culture trays at the
density of 5x105 cells/well. After ethanol treatment for the indicated time, 2.5 µCi

14

C

amino acid mix was added to the wells, incubated at 37°C for 15 minutes and then the
medium was removed; the cells were lysed with 1 vol. cold RIPA buffer. Reactions were
stopped by the addition of 1 vol. cold 20% TCA. The acid insoluble fraction was
collected on Whatman glass fiber filters (47 mM GF/A) and radioactivity was measured
by liquid scintillation counting.
Statistical Analysis:

Differences among treatment groups were tested using analysis of variance
(ANOVA). Differences in which p was less than 0.05 were considered statistically
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significant. In cases where significant differences were detected, specific post-hoc
comparisons between treatment groups were examined with Student-Newman-Keuls test.
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Results
Ethanol induces phosphorylation of PKR and eIF2α in SH-SY5Y, SK-N-MC and
primary cultured rat cerebellar granule cells

Protein synthesis is crucial for maintaining the normal function of the cell.
Reduced organ protein content will decrease the abundance of some critical cellular
components, such as enzymes, and lead to cellular disfunction or cell death. The cellular
protein content is the result of the dynamic balance between rates of protein synthesis and
degradation. Previous studies in some non-neuron cells have already shown that ethanol
exposure can diminish the rate of protein synthesis by upregulating phosphorylation of
eIF2α (67-72). However the upstream kinases that lead to eIF2α phosphorylation have
not been determined. In this study, we first tried to determine if eIF2α was involved in
ethanol-induced protein synthesis inhibition in neural cells; if it is, then what are the
upstream signaling proteins that lead to eIF2α activation? We treated SH-SY5Y, SK-NMC and primary cultured rat cerebellar granule cells with 0.4% ethanol for different time
points and found that phosphorylation of eIF2α was upregulated after ethanol treatment.
Since PKR is the best-known physiological activator of eIF2α, we wondered if PKR was
involved in ethanol-induced eIF2α phosphorylation. We tested the PKR’s activity and
found that, like eIf2α, PKR was also activated by ethanol treatment (Fig. 3.1).

The expression of phosphorylation of PKR and eIF2α is developmentally regulated
and both can be induced by ethanol exposure

To further test the activity of PKR and eIF2α in response to ethanol treatment in
vivo, we examined the expression of total and phosphorylated forms of PKR and eIF2α in
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rat cerebellum. The primary targets of ethanol in the developing central nervous system
are proliferating cells (73) and the neurogenesis of cerebellar granule cells. These
activities occur during the “brain growth spurt” (the third trimester of pregnancy in
human and first two postnatal weeks in the rat), therefore making the brain most
vulnerable to ethanol exposure during this period of time (74). We adopted the pups from
postnatal day (PD) 3 to 21. In early developing cerebellum, the expression of
phosphorylated PKR and eIF2α are gradually increased along its development (Fig.
3.2A). Ethanol exposure during this period of time alters the activation of PKR and
eIF2α. On PD9 or PD4-9, ethanol intubation upregulated the phosphorylation of PKR and
eIF2α in the pups’ cerebellum (Fig. 3.2B, C). This result indicated that both PKR and
eIF2α were activated by ethanol exposure in developing rat cerebellum.
PKR is the activator of eIF2α upon ethanol treatment.

To confirm the role of PKR in the effect of ethanol on eIF2α phosphorylation, two
well known PKR inhibitors (75-77), 2-AP and PKR inhibitor, were used to pre-treat SHSY5Y cells 0.5h before ethanol exposure. Both PKR inhibitors can reduce eIF2α
phosphorylation at concentrations of 10 mM and 500 nM, respectively (Fig. 3.3A, B).
This, most likely, indicates that PKR is an upstream activator of eIF2α in response to
ethanol exposure. Then we further tested the effect of ethanol on eIF2α phosphorylation
in PKR overexpression (PKR+/+) and PKR knock-out (PKR-/-) mouse embryonic
fibroblasts. Ethanol stimulated eIF2α phosphorylation in PKR+/+, but not in PKR-/- cells
(Fig. 3.4). This further suggested the crucial role of PKR in ethanol-induced eIF2α
activation.
PACT/Rax is an upstream activator of PKR/eIF2α upon ethanol exposure
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Ethanol-induced activation of PKR/eIF2α apparently does not involve dsRNA.
So, we wanted to examine the potential upstream activator of PKR. PACT/Rax is a
characterized protein activator of PKR and functions as the physiological mediator of
stress-induced PKR activation in the absence of double-stranded RNA. We sought to
determine whether Rax is involved in ethanol-induced PKR/eIF2α activation. We both
transiently and stably transfected SK-N-MC cells with wild type and S18A (alanine
substitution for serine at position 18) Rax genes. As shown in Fig. 3.5, a positive reaction
of wild type Rax transfected SK-N-MC cells and a negative reaction of S18A transfected
SK-N-MC cells were detected by immunoblots after ethanol exposure compared to vector
control. Since PACT/Rax activates PKR through directly binding to its dsRNA binding
domain, an immunoprecipitation assay was performed to investigate their association
after ethanol treatment. The association of Rax and PKR is increased dramatically in the
widetype transiently and stably transfected cells compared to those vector or mutated Rax
transfected cells (S18A mutated Rax can still bind to PKR but it is kinase deficient (78)
(Fig. 3.6). To confirm that Rax/PKR/eIF2α is the signal transducting pathway leading to
protein synthesis inhibition upon ethanol exposure, a protein synthesis assay was
performed in Rax stably-transfected SK-N-MC cells. The protein synthesis was
dramatically inhibited in Rax over-expression cells, moderately inhibited in vector
transfected cells and slightly inhibited in Rax mutated cells (Fig. 3.7). This result
indicates that the Rax/PKR/eIF2α signal pathway is the major component that mediates
ethanol-induced protein synthesis inhibition.
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Discussion

Heavy, chronic gestational alcohol consumption in pregnant women is detrimental
to the fetus’ developing nervous system. This alcohol abuse can cause fundamental
central nervous system abnormalities known as Fetal Alcohol Syndrome (FAS) in the
infants. One of the hallmarks of FAS is microencephaly that results mainly from the
decreased protein content of the cerebellum (79). Previous studies have established that
ethanol exposure can decrease protein synthesis in some non-neural organs via inhibiting
protein synthesis initiation by regulating the eukaryotic initiation factors (eIFs) in
translational level (80-82). In one study, the phosphorylation of eIF2α, a crucial factor
that controls protein synthesis initiation, can be increased up to 90% by ethanol treatment
(83). We demonstrate that ethanol exposure can also lead to protein synthesis inhibition
in SH-SY5Y, SK-N-MC neuroblastoma cell lines, primary cultured cerebellar granule
cells and rat cerebellum via increasing eIF2α activation. Furthermore, we provide an
important insight into the intracellular signaling pathway that regulates ethanol-induced
phosphorylation of eIF2α and protein synthesis inhibition. In both in vitro and in vivo
experiments, we showed that ethanol exposure induced activation of PKR and led to
phosphorylation of its downstream substrate eIF2α. By using the specific PKR inhibitors,
PKR overexpression and knock-out MEFs, we confirmed that PKR was the direct
activator of eIF2α phosphorylation. We also demonstrated that PACT/Rax was the
upstream activator of PKR in response to ethanol-induced PKR / eIF2α activation and
protein synthesis inhibition by using wildtype and S18A mutated Rax tranfected SK-NMC cells.
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In general, the concentration of ethanol used in vivo is higher than that used in vitro
to produce similar effects. Consequently, the concentrations of ethanol we adopted were
0.4% (40 µg ethanol per ml medium) in vitro and 11.33% in vivo (113.3 µg ethanol per
ml milk formula, roughly equal 0.3% blood ethanol concentration). This is a relatively
high concentration, but it is physiologically relevant to the blood alcohol concentration
reported to cause Fetal Alcohol Syndrome (84).
PKR is the direct upstream activator of eIF2α upon ethanol exposure.

Eukaryotic initiation factor 2 (eIF2), one of a series of proteins that regulated
protein synthesis initiation in eukaryotic cells, is composed of α, β and γ subunits.
Phosphorylation at serine 51 of the α-subunit of eIF2 (eIF2α) blocks the formation of a
ternary initiation complex, which involved eIF2, GTP and Met-tRNAi, and protein
synthesis initiation will be inhibited. The effect of ethanol on protein synthesis at the
molecular level has been investigated previously. Lang et al (85) found that ethanol did
not alter ATP and total RNA content in hepatic cells, but increased the proportion of 40S
and 60S ribosomal subunits in the nonpolysome-associated fraction by 30%, decreased
hepatic eIF2B activity by 36%, and increased eIF2α phosphorylation up to 90%. They
also found similar results in skeletal, muscle and myocardial cells (86;87). Another study
(88) demonstrated that protein synthesis inhibition induced by ethanol could be overcome
by addition of eIF2 in the reticulocyte cell-free system. However none of these studies
have investigated the upstream signal protein(s) leading to eIF2α phosphorylation and
protein synthesis inhibition. So far four eIF2α kinases have been reported, each of them
respond to different stimuli: heme-regulated kinase (HRI) by hemin deprivation (89),
double-stranded RNA-induced protein kinase (PKR) by dsRNA, and PACT/Rax (90;91),
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GCN2 kinase from yeast (92), Drosophila and mouse (93;94) by amino acid or serum
starvation, and PKR-like ER kinase (PERK) by unfolded proteins in response to ERstress (95). All these kinases can lead to eIF2α phosphorylation and translation initiation
inhibition (96-98). Among these kinases, PKR is the best characterized eIF2α kinase, and
recently it has been established that PKR is a component of signal transduction pathways
mediating cell growth and response to different stresses (99). If PKR was the activator of
eIF2α with ethanol treatment, we assumed that PKR should have a synonymous reaction
with eIF2α. Our results confirmed this. Since PERK is another potential protein kinase
that may lead to eIF2α phosphorylation, we checked the p-PERK and total PERK in these
experiments and no synonymous alteration of p-PERK was detected (data not show).
Combined with the results from experiments of PKR inhibitors pre-treatment and PKR
gene knock out MEFs, we demonstrated that PKR is the upstream kinase of eIF2α and is
activated by ethanol exposure.
Ethanol and cerebellum early development

Meanwhile, we investigated the activation of PKR and eIF2α in rat pup’s
cerebellum during postnatal day (PD) 3-21, the western blots showed that
phosphorylation of both was gradually increased, especially after PD9. A possible
explanation is, during this time, cerebellar neurons switched gradually from proliferation
to differentiation. Previous studies have demonstrated that PKR and eIF2α function in
controlling cell proliferation and differentiation (100). Gradually increased activation of
PKR and eIF2α may control cells slowing down their proliferation rate, and release more
mRNAs from polysomes of overall protein synthesis to facilitate the translation of
specific mRNAs that are essential for cellular differentiation processes (101). Our in vivo
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experiments showed that intubating pups with ethanol on PD4 or PD4-9 led to upregulation of PKR and eIF2α activation. The lasting activation of PKR and eIF2α may be
the reason that leads to the decrease protein content in the developing cerebellum after
chronic ethanol exposure.
Intracellular signaling pathway for ethanol action

Two activators of PKR have been reported: dsRNA and PACT/Rax. Since previous
studies have shown that ethanol exposure did not lead to RNA content alteration (102)
and PACT/Rax is the known intracellular PKR mediator in response to different stresses
independent of ds-RNA (103;104), PACT/Rax is likely the activator of PKR/eIF2α in
response to ethanol treatment. To test this hypothesis, we transfected SK-N-MC cells
with wild type and S18A mutated Rax genes both transiently and stably. There are 15
phosphorylatable serines within Rax protein sequence, but only those phosphorylated at
serine 18 are able to activate PKR. The non-phosphorylatable Rax, Rax(S18A), can still
bind with PKR but since it has lost its kinase activity, it fails to induce eIF2α
phosphorylation (105). Our western blots showed that phosphorylation of PKR and eIF2α
were increased significantly in Rax overexpression cells than in Rax mutant cells. Since
Rax activates PKR through direct association, immunoprecipitation experiments were
performed to investigate the interaction between Rax and PKR. Our results demonstrated
that the association between Rax and PKR increased dramatically in wild-type Rax
transfected cells compared to control cells (PKR can not be activated in mutant cells, for
mutant Rax has no kinase activity though its interaction increased). In addition, we
examined the protein synthesis rates in these Rax transfected cells by

14

C amino acids

incorporation assay and the rate is much slower in Rax wildtype cells than in Rax
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mutated (S18A) cells. The conclusion from these experiments is that PACT/Rax-PKReIF2α is the signaling pathway leading to protein synthesis inhibition upon ethanol
exposure in cerebellar granule cells.
Alcohol exposure has a profound effect on central nervous system development.
Our study provides an important insight into a potential mechanism for the effect of
ethanol on the development of CNS.
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Figures
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Figure 3.1 A. SH-SY5Y cells treated with ethanol (0.4%)
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C. Primary cultured cerebellar granule cells treated with ethanol (0.4%)
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Figure 3. 1 Effect of ethanol on PKR and eIF2α activation

PKR and eIF2α are activated by ethanol treatment. The expression of phosphorylated
PKR and eIF2α, total PKR and eIF2α were determined by immunoblots in: A. SH-SY5Y
cells which were cultured in serum-free medium for 24 h then exposed to ethanol (0 or
0.4%). B. 293 cells which were cultured in serum-free medium for 24 h before ethanol (0
or 0.4%) treatment. C. Ethanol (0 or 0.4%) treated primary cultured cerebellar granule
cells. The experiment was replicated three times.
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Fig. 3.2
A. Normal developing cerebellum (PD3-21)
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B. Cerebellum (PD4-9 ethanol treatment)
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Figure 3. 2

Ethanol upregulates phosphorylation of PKR and eIF2α in rat pup's

cerebellum
(A). The expression of phosphorylation of PKR and eIF2α, total PKR and eIF2α were
determined by immunoblots in PD3-21 rat pup’s cerebellum.
(B) and (C). The expression of phosphorylation of PKR and eIF2α increased in pup’s
cerebella which were intubated with ethanol (11.33%) plus milk formula on PD4-9 or
PD9 compared to intubated with milk formula only (control).
The experiment was replicated three times.
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Figure 3. 3 Effect of PKR inhibitors on ethanol-induced eIF2α phosphorylation

PKR inhibitors block ethanol-induced eIF2α activation. SH-SY5Y cells were maintained
in serum-free medium for 24 h then pre-treated with 2-AP (10 mM) (A) or PKR inhibitor
(500 nM) (B) 0.5 h before ethanol (0 or 0.4%) exposure. The expression of
phosphorylation of eIF2α and total eIF2α were determined by immunoblots. The
experiment was replicated three times.
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Figure 3. 4 Ethanol fails to induce eIF2α activation in PKR-deficient MEFs

The PKR+/+ and PKR-/- mouse embryonic fibroblasts were cultured in serum-free
medium for 24 h before ethanol (0 or 0.4%) treatment. The expression of phosphorylation
of eIF2α and total eIF2α were determined by immunoblots. The experiment was
replicated three times.
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Figure 3.5
A

B

103

Figure 3. 5 Effect of ethanol on eIF2α phophorylation in wildtype and serine 18 mutated

Rax transfected SK-N-MC cells
Wildtype Rax gene transfected SK-N-MC cells are more sensitive to ethanol’s action, but
not in Rax mutant transfected SK-N-MC cells. (A). SK-N-MC cells transiently
transfected with wild type or serine 18 mutated Rax genes were cultured in serum-free
medium for 24h before treated with ethanol (0 or 0.4%) for 2, 4 or 6 hours. The
expression of phosphorylation of eIF2α and PKR, total eIF2α and PKR were determined
by immunoblots.
(B). Wild type or serine 18 mutated Rax gene stably transfected SK-N-MC cells were
cultured in serum-free medium for 24 h then exposed to ethanol (0 or 0.4%) for 2, 4 or 6
hours. The expression of phosphorylation of eIF2α and total eIF2α were determined by
immunoblots.
The experiment was replicated three times.
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Figure 3.6
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Figure 3. 6 Ethanol promotes the association between PKR and Rax

Wild type or serine 18 mutated Rax genes were stably transfected in SK-N-MC cells and
exposed to ethanol (0 or 0.4%) after 2, 4 and 6 hs. The association of PKR and Rax or
PKR and HA (tag) was determined by immunoprecipitation using anti-PKR, anti-Rax or
anti-HA antibodies. The experiment was replicated three times.
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Figure 3.7
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Figure 3. 7 Ethanol-induced protein synthesis inhibition was alleviated in Rax mutated

SK-N-MC cells
Protein synthesis was measured in wildtype and S18A mutated Rax stable transfected
SK-N-MC cells treated with 0.4% ethanol by the incorporation 14C labeled amino acids.
The differences among all groups were statistically significant (p<0.05).
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Appendix: Detailed Method
1. Animals and ethanol exposure in vivo

Long-Evans rats were obtained from Harlan-Sprague-Dawley (Indianapolis, IN).
The animals were maintained in a temperature/humidity controlled facility in which the
light/dark cycle was 12 h/12 h and fed with protein-enriched diets that were nutritionally
balanced and met the requirements of pregnant rats (Bio-Serv, Frenchtown NJ). Pups
were anesthetized by injection of ketamine/xylazine and decapitated. Their cerebella
were harvested by cutting through the cerebellar peduncles, frozen on dry ice, and stored
at -80°C for further processing.

2. Immunoblots analysis

Tissues or cells were washed with PBS and lysed with RIPA buffer for 10
minutes. Adherent cell fragments were scraped from the dish and the entire lysate was
transferred to microfuge tubes. Solubilized cells were centrifuged, the proteinaceous
supernatant was collected, and protein concentration was determined by Lowry assay (1).
Aliquots of the supernatant were loaded onto the lanes of a sodium dodecylsulfate (SDS)
7.5~15.0% polyacrylamide gel.

Each aliquot contained 15~60 µg of protein.

The

proteins were separated by electrophoresis, and the separated proteins were transferred to
nitrocellulose membrane. The membranes were washed with 5.0% nonfat dry milk or
Albumin from bovine serum (BSA) in 0.010 M phosphate buffered saline (pH 7.4) and
0.10% Tween-20 (TPBS) at room temperature for one hour to block non-specific
immunoreactivity. Subsequently, the membranes were incubated with primary antibodies
for 1½ hours at room temperature. After two quick washes in TPBS, the membranes
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were incubated with a secondary antibody diluted at 1:1,000~10,000 in TPBS for 1 hour.
The immune complexes were detected with the enhanced chemiluminescence method
(Amersham, Arlington Hts. IL). The blots were stripped and re-probed with an anti- actin
antibody. Since ethanol does not affect the expression of actin, the variation in loading
was normalized against the amount of actin expression in each lane. The relative amount
of protein imaged on the films was quantified using a Sigma Gel program (Jandel, San
Rafael, CA).

3. Cerebellar granule cell culture and ethanol exposure in vitro

Isolation and cultures of cerebellar granule neurons were created using a
previously described method (2-5). Seven-day-old Sprague Dawley rat pups were
decapitated and cerebella carefully removed. The brain tissue was minced with a sterile
razor blade and suspended in 10 ml of trypsine solution (0.025%) at 37°C.

After

incubation for 15 min, an equal volume of a solution containing DNAse (130 Knuitz
units/ml) and trypsine inhibitor (0.75 mg/ml) was added and the tissue was sedimented by
a brief (5 seconds) centrifugation. The tissue was dissociated by trituration, and the cell
suspension was centrifuged through a 4.0% bovine serum albumin solution, which is a
critical step for increasing neuronal viability. The cell pellet was resuspended in Eagle’s
minimal essential medium containing the following supplements: 10.0% fetal bovine
serum (FBS), 25 mM KCL, 1 mM glutamine, 33 mM glucose, and penicillin (100
units/ml)/streptomycin (100 µg/ml).

Cell numbers were determined with a

hemocytometer. Cells were plated at certain densities into poly-D-lysine (PDL)-coated
wells. Cells were incubated at 37°C in a humidified environment containing 5.0% CO2
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for at least 24 hours to permit cell adhesion before initiating further treatment. A method
utilizing sealed containers (6-8) was used to maintain ethanol levels in the culture
medium. With this method, ethanol was added directly to the culture medium in either
tissue culture trays or dishes. Then, the trays or dishes were placed in sealed containers
in which there was an ethanol-containing water bath in the bottom. The concentration of
ethanol in the bath was the same as that in the culture medium. Ethanol from the bath
evaporates into the air of the sealed container and maintains the ethanol concentration in
the culture medium. A small volume of CO2 (60 ml) was injected into the container prior
to sealing. The ethanol bath was changed daily to maintain the ethanol concentration. In
control cultures, the water bath contains no ethanol. All containers were incubated at
37°C. Previous studies have shown that this sealed container method accurately
maintains ethanol concentrations in the culture medium (9).

4. MTT assay

MTT assay is based on the cleavage of the yellow tetrazolium salt MTT [3-(4,5dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide] to purple formazan crystals by
metabolically active cells (10). The MTT assay kit was purchased from Roche Molecular
Biochemicals (Cat. #: 1 465 007, Indianapolis, IN). The cerebellar granule neurons were
plated into 96-well microtiter plates at certain density with total volume of 100µl.
Cultures were then treated with either ethanol or kinases inhibitors. After treatment, ten
microliters of MTT labeling reagent were added to each well and plates were incubated at
37°C for 4 h.

Following MTT incubation, the cultures were solubilized and the

spetrophotometric absorbance of the samples was detected by a microtiter plate reader.
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The wavelength to measure absorbance of formazan product is 570 nm with a reference
wavelength of 750 nm.
5. Immunoprecipitation

Immunoprecipitates were generated with a previous described method (Luo and
Miller, 1999). The cell lysate was collected, and an aliquot containing 200~300 µg of
protein was incubated with antibody against the protein (1:50 in PBS) for overnight at
4°C. Twenty microliters of Protein A/G conjugated to argrose (Santa Cruz Biotech.)
were added to the lysate, and the mixture was incubated 3 hours at 4°C.
Immunoprecipitates were collected by centrifugation at 10,000 x g for 10 min. The pellet
was washed three times with 0.5 ml RIPA buffer [150 mM NaCl, 50 mM Tris (pH 8.0),
1.0% Nonidet P-40, 0.10% SDS, 0.50% deoxycholic acid sodium, 0.10 mg/ml
phenylmethylsulfonyl fluoride, 1.0 mM sodium orthovanadate, and 3.0% Aprotinin
(Sigma)].

After the final wash, the supernatant was aspirated.

The pellet was

resuspended in 20 µl of assay dilution buffer (20 mM MOPs, pH 7.2, 25 mM betaglycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1mM dithiothretol) and
then analyzed it using the procedures described in inmmunoblts analysis.

6. Culture of human neuroblastoma cells expressing inducible TrkB

Human neuroblastoma SH-SY5Y cells expressing inducible TrkB (TB3 and TB8
cells) were generated under the control of a tetracycline (Tet)-repressible promoter
element (11).

Cells were cultured in RPMI 1640 containing 10.0% FBS, 2.0 mM

glutamine and penicillin (100.0 units/ml)/streptomycin (100.0 µg/ml). TB8 cells were
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maintained in a RPMI 1640 medium contained Tet (1.0 µg/ml; Tet-on condition). For
induction of TrkB expression, cells were switched to a Tet-free medium (Tet-off
condition) for further treatment.
7. Apoptosis assay

Accumulation of DNA fragments in the cytoplasm of apoptotic cells was
determined by ELISA (Roche Molecular Biochemicals). We have demonstrated that this
measurement was sensitive to quantify neuronal apoptosis and was consistent with other
morphometric indices of apoptosis (12-14). Briefly, the cells were maintained in 96-well
plates. After treatment, the cultures were washed twice with 0.01 M PBS, and the
cultured cells were lysed. Twenty microliters of cell lysate from each well were mixed
with 80 µl of antibody solution in the coated wells. The loaded wells were incubated at
room temperature for 2 h. Substrate was added to each well after it was washed three
times in incubation buffer. After incubation at room temperature for 10-20 min, the
optical density was measured using a microtiter plate reader with a light filter of 405 nm.
The readings were used to measure the degree of apoptosis.

8. Northern blot analysis

Total RNA was extracted from TB3 and TB8 cells cultured in either Tet-on or
Tet-off conditions.

RNA isolation and hybridization were performed as described

previously (15). Thirty µg of total RNA for TrkB was eletrophoresed in 1.2% agarose6% formaldehyde gels.

Gels were stained with 2 mg/ml ethidium bromide.
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Hybridization was performed with

32

P-labeled insert DNA isolated from a plasmid

containing TrkB (16).

9. Protein synthesis assay

Protein synthesis was measured by incorporation of

14

C labled amino acids

(Amersham CFB104). Cells were seeded in 24-well cell culture trays at the density of
5x105 cells/well. After ethanol treatment for the indicated time, 2.5µCi

14

C amino acid

mix was added to the wells, incubated at 37°C for 15 minutes and then medium was
removed, cells were lysed with 1 vol. cold RIPA buffer. Reactions were stopped by the
addition of 1 vol. Cold 20% TCA. The acid insoluble fraction was collected on Whatman
glass fiber filters (47mM GF/A) and radioactivity was measured by liquid scintillation
counting.
10. Statistics analysis

Differences among treatment groups were tested using analysis of variance
(ANOVA). Differences in which p was less than 0.05 were considered statistically
significant. In cases where significant differences were detected, specific post-hoc
comparisons between treatment groups were examined with Student-Newman-Keuls
tests.
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